Esketamine Prevents Treatment-Resistant Depression Relapse.

OPEN Foundation
October 22, 2019

Slomski, A. (2019). Esketamine Prevents Treatment-Resistant Depression Relapse. 22, 322(16), 1544-1544.
Link to full text

OPEN Foundation

Share This Post

get the latest

The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!

By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

Recent articles & news

The Global Psychedelic Survey 2025: A Study of International Naturalistic Psychedelic Use

Who Benefits from the Psychedelic Renaissance?

Psychedelics and Autonomy – From the Field

Affect and Psychedelic Therapy: From Raw Emotion to Narrative Memory

An Open Letter Reply to Dr. Stan Grof

Psychedelics and Nature – From the Field

Music in Psychedelic Practices – From the Field

Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions

Comparing Psychedelic-Assisted Therapy with Traditional Therapy for Mental Illnesses – Part 2

Esketamine Prevents Treatment-Resistant Depression Relapse.

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS